Аntithrombotic prophylaxis and therapy in oncology
In the article the authors revise a number of methods used in clinic for the description of hypercoagulation syndrome and consider that persistent trombinemia signs and signs of platelet hyperaggregation with the increased consumption of them are the most reliable markers of hypercoagulation and pre...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2003-09-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/3796 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849403346802180096 |
|---|---|
| author | Z. S. Barkagan A. N. Shilova S. A. Khodorenko |
| author_facet | Z. S. Barkagan A. N. Shilova S. A. Khodorenko |
| author_sort | Z. S. Barkagan |
| collection | DOAJ |
| description | In the article the authors revise a number of methods used in clinic for the description of hypercoagulation syndrome and consider that persistent trombinemia signs and signs of platelet hyperaggregation with the increased consumption of them are the most reliable markers of hypercoagulation and prethrombosis state. Methodology of oncothrombosis prophylaxis and therapy is discussed. Authors demonstrate that heparin therapy decreases the risk of development of spontaneous and postsurgery thrombosis as well as of DIC-syndrome in cancer patients. Authors define the ways of further optimization of thrombotic complications prophylaxis and therapy using thrombine inhibitors and the study of their effects on oncogenesis. |
| format | Article |
| id | doaj-art-d7b6a069dab44eb391114740fbd99c4e |
| institution | Kabale University |
| issn | 1682-0363 1819-3684 |
| language | English |
| publishDate | 2003-09-01 |
| publisher | Siberian State Medical University (Tomsk) |
| record_format | Article |
| series | Бюллетень сибирской медицины |
| spelling | doaj-art-d7b6a069dab44eb391114740fbd99c4e2025-08-20T03:37:17ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842003-09-012391810.20538/1682-0363-2003-3-9-182414Аntithrombotic prophylaxis and therapy in oncologyZ. S. Barkagan0A. N. Shilova1S. A. Khodorenko2Алтайский государственный медицинский университет; Алтайский онкологический диспансерАлтайский государственный медицинский университет; Алтайский онкологический диспансерАлтайский государственный медицинский университет; Алтайский онкологический диспансерIn the article the authors revise a number of methods used in clinic for the description of hypercoagulation syndrome and consider that persistent trombinemia signs and signs of platelet hyperaggregation with the increased consumption of them are the most reliable markers of hypercoagulation and prethrombosis state. Methodology of oncothrombosis prophylaxis and therapy is discussed. Authors demonstrate that heparin therapy decreases the risk of development of spontaneous and postsurgery thrombosis as well as of DIC-syndrome in cancer patients. Authors define the ways of further optimization of thrombotic complications prophylaxis and therapy using thrombine inhibitors and the study of their effects on oncogenesis.https://bulletin.ssmu.ru/jour/article/view/3796hypercoagulation syndrometrombinemiaoncothrombosis therapy |
| spellingShingle | Z. S. Barkagan A. N. Shilova S. A. Khodorenko Аntithrombotic prophylaxis and therapy in oncology Бюллетень сибирской медицины hypercoagulation syndrome trombinemia oncothrombosis therapy |
| title | Аntithrombotic prophylaxis and therapy in oncology |
| title_full | Аntithrombotic prophylaxis and therapy in oncology |
| title_fullStr | Аntithrombotic prophylaxis and therapy in oncology |
| title_full_unstemmed | Аntithrombotic prophylaxis and therapy in oncology |
| title_short | Аntithrombotic prophylaxis and therapy in oncology |
| title_sort | аntithrombotic prophylaxis and therapy in oncology |
| topic | hypercoagulation syndrome trombinemia oncothrombosis therapy |
| url | https://bulletin.ssmu.ru/jour/article/view/3796 |
| work_keys_str_mv | AT zsbarkagan antithromboticprophylaxisandtherapyinoncology AT anshilova antithromboticprophylaxisandtherapyinoncology AT sakhodorenko antithromboticprophylaxisandtherapyinoncology |